Research Paper Volume 13, Issue 22 pp 24621—24639

Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma

class="figure-viewer-img"

Figure 6. Comparison of the GILncSig with TP53 mutation status in prognosis value. (A) The proportion of TP53 mutation in high- and low-risk groups in the training set, testing set and the TCGA set. (B) Kaplan–Meier curve analysis of overall survival is shown for patients classified according to TP53 mutation status and the GILncSig. Statistical analysis was performed using the log-rank test.